The rates are remarkably similar across all three, despite their different mechanisms: Semaglutide: Nausea approximately 18%, diarrhea approximately 12%, vomiting approximately 8% Tirzepatide: Nausea 17-22% (dose dependent), diarrhea 13-16%, vomiting 6-10% Retatrutide: Nausea 16-25% (dose dependent), diarrhea 15-22%, vomiting 8-13% The pattern holds consistently
placebo, respectively)
According to the brand's Terms of Service, healthcare providers using the platform are independent medical professionals responsible for the medical care they provide, and a prescription is only issued if a provider determines treatment is clinically appropriate
But when the body experiences a big shock like illness, childbirth, surgery, or rapid weight loss, many follicles suddenly shift into the shedding phase
Tirzepatide, acting on both GIP and GLP-1 receptors, is effective in reducing weight and controlling glucose, providing superior weight loss effects
Much of the ipamorelin and CJC-1295 in circulation is sold as a "research chemical," outside the controls that govern legitimate pharmaceutical and compounded products